This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
| Synonym(s) | 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide |
| Grade | pharmaceutical primary standard |
| API family | sorafenib |
| format | neat |
| storage temp. | 2-8°C |
| SMILES string | FC(F)(F)c1c(ccc(c1)NC(=O)Nc2ccc(cc2)Oc3cc(ncc3)C(=O)NC)Cl |
| InChI | 1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31) |
| InChI key | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Safety Information
- Signal Word : Danger
- Hazard Statements : H360FD,H362,H372,H410
- Precautionary Statements: P202 – P260 – P263 – P264 – P273 – P308 + P313
- Hazard Classifications : Aquatic Acute 1 – Aquatic Chronic 1 – Lact. – Repr. 1B – STOT RE 1
- WGK : WGK 3
Reviews
There are no reviews yet.